Edge Pharma recalls sterile ophthalmic solution for injection due to lack of sterility assurance. This may cause infections if used improperly. Contact for details.
Lack of Assurance of Sterility
Edge Pharma is recalling a specific ophthalmic solution for injection because it may not be sterile. Using this product could lead to eye infections if it's not properly sterilized.
The solution may not be sterile, which can lead to infections if used in the eye. This is a risk for patients undergoing eye procedures or injections.
People who have received this specific ophthalmic solution for eye injections. Those with medical conditions requiring injections are at higher risk.
Check for the product name 'Ceftazidime, Sterile Ophthalmic Solution for Injection, Preservative Free' with NDC 05446-0733-01. It was sold between December 2021 and January 2022.
Look for the NDC code 05446-0733-01 on the product label.
The product may not be sterile, which could cause eye infections. Do not use it.
Check for the NDC code 05446-0733-01 on the product label. It was sold between December 2021 and January 2022.
Do not use it. Contact Edge Pharma for further instructions.
We’ve drafted a message you can send Edge Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0397-2022 — Edge Pharma Edge Pharma Hello, I own a Edge Pharma that is covered by recall D-0397-2022 from Edge Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
